常铝股份(002160) - 2019 Q4 - 年度财报

Financial Performance - The company's operating revenue for 2019 was ¥4,330,649,784.47, representing a 4.66% increase compared to ¥4,137,649,981.51 in 2018[24]. - The net profit attributable to shareholders for 2019 was ¥21,980,735.15, a significant turnaround from a loss of ¥430,349,492.60 in 2018, marking a 105.11% increase[24]. - The net cash flow from operating activities reached ¥269,038,872.58, a remarkable increase of 367.26% from -¥100,663,901.40 in the previous year[24]. - The company's total assets decreased by 6.21% to ¥6,001,705,834.60 at the end of 2019, down from ¥6,399,315,028.51 in 2018[25]. - The net assets attributable to shareholders increased by 4.17% to ¥3,026,165,804.48, compared to ¥2,905,065,814.63 at the end of 2018[25]. - The company reported a basic earnings per share of ¥0.03 for 2019, a significant improvement from -¥0.59 in 2018, reflecting a 105.08% increase[24]. - The company achieved a total revenue of CNY 4.33 billion in 2019, representing a year-on-year growth of 4.66%[43]. - The net profit attributable to shareholders was CNY 21.98 million, marking a turnaround from a loss in the previous year[43]. Business Strategy and Expansion - The company has expanded its business into the pharmaceutical sector through the acquisition of Langmai Co., enhancing its risk resilience[8]. - The company’s main business has evolved to include aluminum foil, aluminum materials, and pharmaceutical manufacturing, diversifying its revenue streams[22]. - The company plans to focus on expanding market share, particularly in the alloy materials sector, to ensure sustainable development[45]. - The company aims to enhance internal control management to ensure product quality and customer satisfaction[46]. - The company is committed to strengthening collaboration among subsidiaries to leverage the advantages of the entire industrial chain[48]. - The company will continue to adjust its product structure and promote industrial transformation and upgrading[49]. - The company plans to invest RMB 180 million in the pharmaceutical equipment production project, with RMB 153.89 million sourced from raised funds[77]. - The company aims to continue its dual business strategy of "aluminum processing + health" to enhance competitiveness and promote sustainable development[83]. Governance and Compliance - The company’s financial report is verified by the accounting firm Lixin, ensuring the accuracy and completeness of its financial statements[23]. - The company has established a comprehensive corporate governance structure to protect the rights of shareholders and creditors[126]. - The company emphasizes employee rights and welfare, ensuring compliance with labor laws and providing various benefits[127]. - The company has fulfilled its commitments regarding avoiding competition with related parties during the reporting period[93]. - The company will strictly adhere to relevant laws and regulations regarding related party transactions and ensure fair decision-making processes[95]. - The company has no significant discrepancies with the regulatory requirements for corporate governance as per the China Securities Regulatory Commission[182]. - The remuneration for independent directors and senior management was reviewed and deemed reasonable and compliant with decision-making procedures[192]. Shareholder Information - The company’s stock is listed on the Shenzhen Stock Exchange under the code 002160, indicating its public trading status[18]. - The company has not experienced any changes in its controlling shareholder since its listing, maintaining stability in ownership[22]. - The largest shareholder, Changshu Aluminum Foil Factory Co., Ltd., holds 23.31% of the shares, totaling 185,457,926 shares[148]. - The second largest shareholder, Shanghai Langyi Industrial Development Co., Ltd., holds 5.51% of the shares, totaling 43,860,873 shares[148]. - The company reported a significant increase in shareholder structure with three new investors participating in the private placement[144]. - The company has a total of 43,219 ordinary shareholders as of the end of the reporting period[146]. Employee and Labor Relations - The total number of employees in the company is 1,957, with 444 in the parent company and 1,531 in major subsidiaries[175]. - The professional composition includes 1,132 production personnel, 121 sales personnel, 240 technical personnel, 58 financial personnel, 167 administrative personnel, and 239 auxiliary production personnel[175]. - The educational background of employees shows 15 with master's degrees or above, 384 with bachelor's degrees, and 1,558 with college diplomas or below[176]. - The company follows the Labor Law of the People's Republic of China and local labor contract regulations for its compensation policy[177]. - The company has established a comprehensive training system, including onboarding and ongoing training, to enhance employee skills and align with corporate culture[178]. Research and Development - Research and development expenses for 2019 amounted to ¥140,339,494.10, reflecting an 8.77% increase from the previous year, with R&D expenses accounting for 3.24% of total revenue[62]. - The number of R&D personnel increased by 30.19% to 345, although their proportion of total employees slightly decreased to 17.63%[63]. Environmental and Social Responsibility - The company has established an ISO14001 environmental management system since 2006, focusing on waste management and pollution control, which has been recognized by local environmental authorities[133]. - The company actively participates in social welfare activities, contributing to various charitable initiatives such as poverty alleviation and support for underprivileged students[129]. - The company has not initiated any precision poverty alleviation projects during the reporting period and has no subsequent plans[130]. Financial Management and Investments - The company has a foreign investment of €200,000 in Finland for research, production, and sales, with a financial audit confirming no significant impairment risks[38]. - The total amount of raised funds in 2015 and 2016 was CNY 111,598,000, with CNY 97,638,840 utilized, representing 87.39% of the total[73]. - In 2019, the company raised CNY 10,764,000, with CNY 800,000 utilized, indicating 7.43% of the total[73]. - The company has entrusted CNY 70 million in financial management, with an outstanding balance of CNY 10 million[122]. - The company has no overdue amounts in the entrusted financial management[122]. Legal and Regulatory Matters - There are ongoing litigation matters, including a contract dispute with Jiangsu Jiedandi Machinery Manufacturing Co., Ltd. involving 1.4692 million yuan, which has been resolved[103]. - The company has no major litigation or arbitration matters that could materially affect its financial position[102]. - The company has not engaged in any major related party transactions during the reporting period[108]. Internal Control and Audit - The audit committee held seven meetings during the reporting period, ensuring compliance and accuracy in financial reporting[191]. - The company’s financial statements for 2019 received a standard unqualified audit opinion from the auditing firm, confirming their accuracy and compliance with accounting standards[192]. - The internal control self-assessment report indicated that the company maintained effective internal controls related to financial statements as of December 31, 2019[199].